First human test for rare hormone disorder treatment begins
NCT ID NCT07195175
Summary
This is the first study testing a new drug called MAR002 in people. Researchers want to check if it's safe and how the body processes it in 45 healthy men. The drug is being developed for acromegaly, a rare hormonal disorder, but this early phase only looks at safety in healthy volunteers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Marea Site
RECRUITINGTempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.